LONDON/COPENHAGEN, April 2 (Reuters) - Novo Holdings, the controlling shareholder of obesity drugmaker Novo Nordisk (NOVOb.CO), opens new tab, nearly doubled annual income and investment returns ...
Europe’s largest pharmaceutical firm, Novo Nordisk, saw its stocks tumble 27% in March, marking their worst monthly performance since July 2002. As of market close on 31 March, the Danish firm ...
Novo Holdings, the controlling shareholder of obesity drugmaker Novo Nordisk, nearly doubled annual income and investment returns to a record €8 billion in 2024, it said today. Fuelled by ...
The C Button on the Nintendo Switch 2 controls the console's Game Chat feature, allowing for screen sharing and chatting while gaming. Players will receive early access to Game Chat from the ...
After months of speculation, we now know what happens when you press the Switch 2’s mysterious C button thanks to today’s Nintendo Direct presentation. The C button is all about Game Chat ...
Another Switch 2 C button tease has arrived courtesy of the Nintendo Today app, on the eve of the big Switch 2 Direct. While we still don't know what the mystery button does, we now know what ...
Danish drugmaker Novo Nordisk has been dethroned by German software giant SAP as Europe’s most valuable company. SAP has soared some 40 per cent over the last year as investors celebrated its ...
During the April 2025 Nintendo Direct, Nintendo has finally revealed what the mysterious “C” button on the right Joy-Con on Nintendo Switch 2. It’ll allow players to do a variety of ...
Novo Holdings' $16.5 billion acquisition of US contract development and manufacturing organisation (CDMO) Catalent has been completed, after months of debate over potential antitrust issues.
Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results